Evidence map›Paper›PMID 35924866›Full record

ArticleACS infectious diseases2022

Investigating Peptidoglycan Recycling Pathways in

Kimberly A Wodzanowski, Stephen N Hyland, Sreedevi Chinthamani, Liam-Michael D Sandles, Kiyonobu Honma, Ashu Sharma, Catherine L Grimes

Open access · greenAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in ACS infectious diseases, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
1.2field-weighted citation impact, top 22% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 9 citations in OpenAlex.

  1. ACS infectious diseases · 2026
    Article
  2. Review
  3. Obtaining Muramic Acid fromLife (Basel, Switzerland) · 2025
    Article
  4. Review
  5. Minimalist TetrazineJournal of the American Chemical Society · 2024
    Article
  6. Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 1 country.

Kimberly A WodzanowskiDepartment of Chemistry and Biochemistry, University of Delaware, Newark, Delaware 19716, United States.ORCID 0000-0001-8948-6788
Stephen N HylandDepartment of Chemistry and Biochemistry, University of Delaware, Newark, Delaware 19716, United States.
Sreedevi ChinthamaniDepartment of Oral Biology, University at Buffalo, State University of New York, Buffalo, New York 14214, United States.
Liam-Michael D SandlesDepartment of Chemistry and Biochemistry, University of Delaware, Newark, Delaware 19716, United States.
Kiyonobu HonmaDepartment of Oral Biology, University at Buffalo, State University of New York, Buffalo, New York 14214, United States.
Ashu SharmaDepartment of Oral Biology, University at Buffalo, State University of New York, Buffalo, New York 14214, United States.
Catherine L GrimesDepartment of Chemistry and Biochemistry, University of Delaware, Newark, Delaware 19716, United States.ORCID 0000-0002-0586-2879
University of Delaware · USUniversity at Buffalo, State University of New York · US

Funding

This renovation project will create over 1455 sq. ft. of state- of-the-art reseaP20GM104316 · NIGMS · UNIVERSITY OF DELAWARE · PI FOX, JOSEPH M · 2014 to 2024
$26.8M
Pilot Research Subproject ProgramP30GM110758 · NIGMS · UNIVERSITY OF DELAWARE · PI POLENOVA, TATYANA · 2014 to 2018
$5.8M
Chemistry-Biology Interface Predoctoral Training Grant 2024-2029T32GM133395 · NIGMS · UNIVERSITY OF DELAWARE · PI Catherine Leimkuhler Grimes · 2019 to 2026
$3.7M
Bacterial sialometabolic activity impacts periodontal immunity and microbiotaR01DE029497 · NIDCR · STATE UNIVERSITY OF NEW YORK AT BUFFALO · PI SHARMA, ASHU · 2021 to 2025
$1.8M
Metabolic carbohydrate cell wall probes for bacterial structure and immune recognition studiesU01CA221230 · NCI · UNIVERSITY OF DELAWARE · PI GRIMES, CATHERINE LEIMKUHLER · 2017 to 2019
$1.1M
NCI NIH HHS U01 CA221230NIDCR NIH HHS R01 DE029497NIGMS NIH HHS P20 GM104316NIGMS NIH HHS P30 GM110758NIGMS NIH HHS T32 GM133395
6 · The paper itself

Abstract

The human oral microbiome is the second largest microbial community in humans, harboring over 700 bacterial species, which aid in digestion and protect from growth of disease-causing pathogens. One such oral pathogen,

Indexed as

PeptidoglycanPseudomonas putidaCell WallEscherichia coliHumansMuramic AcidsTannerella forsythiaMuramic AcidsN-acetylmuramic acidPeptidoglycanbacterial cell-wall remodelingbacterial pathogenesisbioorthogonalN-acetylmuramic acid probesoral microbiomepeptidoglycan

Identifiers

PMID35924866
PMCPMC9464701
OpenAlexW4289842267

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.